Liver Cirrhosis

"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Descriptor ID	D008103
MeSH Number(s)	C06.552.630
Concept/Terms	Liver Cirrhosis Liver Cirrhosis Cirrhosis, Liver Cirrhoses, Liver Liver Cirrhoses Hepatic Cirrhosis Cirrhoses, Hepatic Cirrhosis, Hepatic Hepatic Cirrhoses Fibrosis, Liver Fibrosis, Liver Fibroses, Liver Liver Fibroses Liver Fibrosis

Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Liver Cirrhosis [C06.552.630]

Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.

Bar chart showing 39 publications over 19 distinct years, with a maximum of 5 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2003	1	2	3
2005	1	0	1
2006	1	1	2
2007	1	0	1
2008	0	1	1
2009	1	0	1
2011	1	0	1
2013	1	1	2
2014	0	3	3
2015	1	1	2
2017	3	1	4
2018	2	0	2
2019	1	1	2
2020	3	1	4
2021	1	1	2
2022	0	1	1
2023	1	4	5
2024	0	1	1

Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.

Yamada A, Watanabe A, Nara A, Ishimaru N, Maeda K, Ido Y, Kotake K, Asano M, Shinohara Y, Yamamoto T. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. Int J Mol Sci. 2024 Jun 04; 25(11).

View in: PubMed
Bangaru S, Sundaresh R, Lee A, Prause N, Hao F, Dong TS, Tincopa M, Cholankeril G, Rich NE, Kawamoto J, Bhattacharya D, Han SB, Patel AA, Shaheen M, Benhammou JN. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484.

View in: PubMed
Kanwal F, Nelson R, Liu Y, Kramer JR, Hernaez R, Cholankeril G, Rana A, Flores A, Smith D, Cao Y, Beech B, Asch SM. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.

View in: PubMed
Hang Y, Lee C, Roman YM. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East?Asian populations. Biomark Med. 2023 04; 17(8):445-454.

View in: PubMed
Makrogiannis S. Editorial for "Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated from the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis". J Magn Reson Imaging. 2023 11; 58(5):1579.

View in: PubMed
Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang JY. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. Int J Mol Sci. 2023 Feb 13; 24(4).

View in: PubMed
Rabiee A, Gay MD, Shivapurkar N, Cao H, Nadella S, Smith CI, Lewis JH, Bansal S, Cheema A, Kwagyan J, Smith JP. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis. Clin Pharmacol Ther. 2022 12; 112(6):1271-1279.

View in: PubMed
Mawson AR, Croft AM, Gonzalez-Fernandez F. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis. Viral Immunol. 2021 Jul-Aug; 34(6):376-379.

View in: PubMed
Tamargo JA, Sherman KE, Campa A, Martinez SS, Li T, Hernandez J, Teeman C, Mandler RN, Chen J, Ehman RL, Baum MK. Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV. Am J Clin Nutr. 2021 03 11; 113(3):593-601.

View in: PubMed
Xie G, Wang X, Wei R, Wang J, Zhao A, Chen T, Wang Y, Zhang H, Xiao Z, Liu X, Deng Y, Wong L, Rajani C, Kwee S, Bian H, Gao X, Liu P, Jia W. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med. 2020 06 05; 18(1):144.

View in: PubMed

People

Explore

Similar Concepts

Top Journals